Controlled Substance Prescription Refill Rules (2026): Transfers, E-Prescribing & State Laws

Disclaimer: This article is for educational purposes only and does not constitute legal or clinical advice. Always verify your state's specific controlled substance rules with your board of pharmacy.

---

What are the rules for prescribing controlled substances?

Prescribing rules for controlled substances operate on two regulatory layers: federal law (the Controlled Substances Act and DEA regulations under 21 CFR Part 1306) and state pharmacy/medical board rules that often impose stricter requirements.

Every controlled substance prescription must satisfy federal baseline requirements and any additional state-specific rules. When federal and state law conflict, the more restrictive rule applies.

The practical compliance questions—can this be refilled? Can it be called in? Can I prescribe across state lines?—all depend on the drug's schedule (II through V), the prescription method (written, electronic, oral), and the state where the patient fills it.

For guidance on who can prescribe controlled substances, see our guides to Nurse Practitioner Prescribing Authority by State and Physician Assistant Prescribing Authority by State.

---

5 Legal Requirements for a Controlled Substance Prescription

Under 21 CFR 1306.05, every controlled substance prescription must contain five elements to be valid [1]:

1. Patient full name and address
2. Practitioner's name, address, and DEA registration number
3. Drug name, strength, dosage form, and quantity prescribed
4. Directions for use
5. Date of issuance and practitioner's signature (manual signature required for Schedule II; manual or electronic for Schedule III–V)

A prescription missing any of these elements is technically invalid. Pharmacists have a corresponding responsibility (21 CFR 1306.04) to verify that a prescription was issued for a legitimate medical purpose by a practitioner acting in the usual course of professional practice [1].

For a deeper dive on pharmacist verification duties, see our guide to Pharmacist Corresponding Responsibility & Red Flags.

---

Controlled Substance Prescription Refill Rules by Schedule

The refill rules are where practitioners and pharmacists encounter the most confusion—and the most compliance risk. Federal law draws hard lines by schedule [2] [3]:

Schedule II: No Refills, Period

Can controlled substances have refills if they're Schedule II? No. Oxycodone, Adderall, fentanyl, methylphenidate, and other Schedule II drugs require a new prescription every time [2].

However, practitioners can write multiple prescriptions on the same date for up to a 90-day supply, with instructions such as "Do not fill until [date]" on each [3]. This is a common workaround for stable patients on long-term Schedule II therapy.

Schedule III–IV: 5 Refills in 6 Months

Prescriptions for Schedule III–IV drugs (e.g., Tylenol with codeine, testosterone, Xanax, Ambien, tramadol) may be refilled up to 5 times within 6 months of the date originally written—whichever limit is reached first [2].

Schedule V: Refills as Authorized

Schedule V drugs (e.g., certain cough preparations with low-dose codeine, pregabalin in some states) have no federal cap on refills. The prescriber determines the number of authorized refills [2].

The "28-Day Rule" — Insurance, Not Law

The so-called 28-day rule is not a DEA regulation. It's an insurance and pharmacy practice: most payers require 85% of a controlled substance supply to be consumed before authorizing a refill [4]. For a 30-day supply, that means refills are typically available around day 25–28. This threshold varies by plan, state, and pharmacy chain.

---

Can Controlled Substances Be Called In?

Can controlled substances be called in to a pharmacy by phone? The answer splits by schedule [1]:

• Schedule III–V: Yes. Oral (phone) prescriptions are permitted as standard practice. The practitioner or their authorized agent may call in the prescription.
• Schedule II: Generally no. Schedule II prescriptions must be written (paper) or electronic. The sole exception is a genuine emergency, where the practitioner personally (not an agent) may call in a Schedule II prescription. A written or electronic follow-up prescription must be delivered to the pharmacy within 7 days [1].

What qualifies as an emergency? The DEA defines it as a situation where: (1) immediate administration is necessary for proper treatment, (2) no appropriate alternative treatment is available, and (3) it is not reasonably possible for the practitioner to provide a written prescription before dispensing [1].

---

Can Controlled Substance Prescriptions Be Transferred?

Can controlled substances be transferred between pharmacies? Yes, but the rules depend on schedule and prescription type [5] [6]:

Schedule III–V Refill Transfers

Prescriptions with remaining refills can be transferred between pharmacies on a one-time basis [5]. The transfer must be communicated directly between two licensed pharmacists. Both pharmacies must document the transfer, including:

• Date of transfer
• Name of transferring/receiving pharmacist
• DEA number of transferring pharmacy
• Number of refills remaining

Exception: Pharmacies sharing a real-time, online database (e.g., chain pharmacies on the same system) may transfer prescriptions up to the maximum refills permitted [5].

Schedule II–V Electronic Prescription Transfers (2023 Rule)

Since August 28, 2023, the DEA allows the one-time transfer of unfilled electronic prescriptions for Schedule II–V drugs between retail pharmacies at the patient's request [6]. Key requirements:

• The prescription must remain in electronic form throughout the transfer
• No intermediary may convert it to paper or fax
• The transfer must be communicated directly between two licensed pharmacists
• State law must also permit the transfer

Schedule II Paper Prescriptions

Schedule II paper prescriptions cannot be transferred. The patient must return to the original pharmacy or obtain a new prescription.

---

Partial Filling of Schedule II Prescriptions

Under the Comprehensive Addiction and Recovery Act (CARA) of 2016, pharmacists may partially fill a Schedule II prescription under two scenarios [7]:

1. Pharmacist unable to supply full quantity: The remaining portion must be filled within 72 hours. If not, the pharmacist must notify the prescriber and the remaining portion is voided.
2. Patient or prescriber requests a partial fill: All partial fills must be completed within 30 days of the date issued. The total quantity across all partial fills cannot exceed the originally prescribed amount.

Documentation requirements include noting the request type, date, quantity dispensed, and pharmacist initials on the prescription record [7].

---

Prescribing Controlled Substances Across State Lines

Prescribing controlled substances across state lines is one of the most misunderstood areas of controlled substance law. Here's how the two regulatory layers interact [8] [9]:

Federal Layer

Under federal law, a DEA-registered practitioner may prescribe controlled substances to a patient located in another state. The DEA does not require a separate registration in each state where patients are located—for standard (non-telemedicine) prescribing [8].

State Layer

This is where it gets complicated. States control:

• Practitioner licensure: Most states require the prescriber to hold a license (or equivalent authorization) in the state where the patient is located
• Pharmacy dispensing: The pharmacy filling the prescription must be licensed in the state where it operates and must verify the prescription is valid under that state's law
• Schedule-specific restrictions: Some states prohibit certain schedules for out-of-state prescribers or impose additional documentation requirements

Pharmacist Obligations for Out-of-State Prescriptions

A pharmacist receiving a controlled substance prescription from an out-of-state practitioner must verify [8]:

1. The practitioner holds a valid DEA registration
2. The prescription meets federal requirements (21 CFR 1306.05)
3. The prescription complies with both the prescriber's state and the dispensing state's laws
4. The prescription was issued for a legitimate medical purpose

When state laws conflict, the more restrictive rule governs.

---

Controlled Substance E-Prescribing (EPCS) Requirements

Controlled substance e-prescribing has shifted from optional to mandatory across most of the country. Requirements operate at two levels [10] [11]:

Federal Mandate (Medicare Part D)

Since 2023, CMS requires Medicare Part D prescribers to transmit at least 70% of all Schedule II–V controlled substance prescriptions electronically [10]. Exemptions exist for prescriptions issued during emergencies, veterinary prescriptions, and certain institutional settings.

State EPCS Mandates (2026)

Over 35 states have enacted their own EPCS mandates, many covering all controlled substances (not just Medicare Part D). The scope varies significantly [11]:

EPCS Compliance Requirements

For practitioners, EPCS compliance requires [10]:

• DEA registration with an approved EPCS application
• Two-factor authentication (e.g., biometric + password, or hard token + password)
• Identity proofing through a credential service provider
• Third-party audit of the EPCS software application

---

Prescribing Controlled Substances via Telehealth

Prescribing controlled substances via telehealth adds a third regulatory layer on top of state and federal prescription rules [12]:

Current Status (Through December 31, 2026)

The DEA and HHS have extended the full set of COVID-era telemedicine flexibilities through the end of 2026 [12]. This means DEA-registered practitioners can prescribe Schedule II–V controlled substances via telemedicine without a prior in-person evaluation, provided they meet applicable state requirements.

After 2026: DEA Telemedicine Special Registration

On January 17, 2025, the DEA proposed three rules to establish a permanent framework for telemedicine prescribing of controlled substances [12]:

• Special Registration for Telemedicine: Allows prescribing Schedule II–V drugs without an in-person visit if the practitioner holds this registration, conducts a nationwide PDMP check, and verifies patient identity via audio-video technology
• Limited State Telemedicine Registration: A state-specific alternative for practitioners operating in fewer states
• Buprenorphine exception: A separate final rule allows buprenorphine induction for opioid use disorder via audio-only telemedicine without the Special Registration

For the full telehealth compliance analysis, see our guide to The 2026 Telehealth Compliance Trap.

---

Quick Reference: Controlled Substance Prescription Rules Summary

---

---

References

1. https://pmc.ncbi.nlm.nih.gov/articles/PMC3847977/

2. https://www.ecfr.gov/current/title-21/chapter-II/part-1306/subject-group-ECFRe4ae2bfb4eae102/section-1306.22

3. https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section829&num=0&edition=prelim

4. https://perks.optum.com/blog/28-day-prescription-rule-controlled-substance

5. https://www.ecfr.gov/current/title-21/chapter-II/part-1306/subject-group-ECFRe4ae2bfb4eae102/section-1306.25

6. https://www.dea.gov/stories/2023/2023-09/2023-09-01/revised-regulation-allows-dea-registered-pharmacies-transfer

7. https://www.jblearning.com/blog/jbl/2023/11/08/filling-schedule-ii-prescriptions-changes-in-federal-law

8. https://www.deadiversion.usdoj.gov/GDP/(DEA-DC-85)(EO-DEA180)_Filling_CS_Rx_from_Out_of_State_Pract_(Final).pdf

9. https://connectwithcare.org/dea-prescribing-of-controlled-substances/

10. https://www.cms.gov/medicare/e-health/eprescribing/cms-eprescribing-for-controlled-substances-program

11. https://ensorahealth.com/blog/e-prescribing-laws-by-state/

12. https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth